Compare BIO & HQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | HQY |
|---|---|---|
| Founded | 1952 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Business Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 7.9B |
| IPO Year | N/A | 2014 |
| Metric | BIO | HQY |
|---|---|---|
| Price | $261.51 | $76.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $358.50 | $115.93 |
| AVG Volume (30 Days) | 296.4K | ★ 835.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 70.31 |
| EPS | N/A | ★ 1.88 |
| Revenue | N/A | ★ $229,525,000.00 |
| Revenue This Year | $2.51 | $10.44 |
| Revenue Next Year | $3.17 | $7.47 |
| P/E Ratio | ★ $9.72 | $41.80 |
| Revenue Growth | N/A | ★ 28.68 |
| 52 Week Low | $211.43 | $72.76 |
| 52 Week High | $343.12 | $116.65 |
| Indicator | BIO | HQY |
|---|---|---|
| Relative Strength Index (RSI) | 33.81 | 44.72 |
| Support Level | $251.00 | $73.82 |
| Resistance Level | $264.68 | $79.75 |
| Average True Range (ATR) | 7.45 | 2.93 |
| MACD | -0.12 | 0.47 |
| Stochastic Oscillator | 2.39 | 28.14 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.